Early high-volume hemofiltration versus standard care for post-cardiac surgery shock the HEROICS study

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 10, 2015, Pages 1179-1190

  Combes, Alain ^a   Bréchot, Nicolas ^a   Amour, Julien ^a   Cozic, Nathalie ^a   Lebreton, Guillaume ^a   Guidon, Catherine ^b   Zogheib, Elie ^c   Thiranos, Jean Claude ^d   Rigal, Jean Christophe ^e   Bastien, Olivier ^f   Benhaoua, Hamina ^g   Abry, Bernard ^h   Ouattara, Alexandre ⁱ   Trouillet, Jean Louis ^a   Mallet, Alain ^a   Chastre, Jean ^a   Leprince, Pascal ^a   Luyt, Charles Edouard ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b TIMONE HOSPITAL   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h Clinique Jacques Cartier   (France)

ⁱ UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Cardiac surgery; High volume hemofiltration; Mortality; Randomized controlled trial

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; CATECHOLAMINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; NORADRENALIN; PHOSPHATE; POTASSIUM; TRACE ELEMENT; VITAMIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CARDIOGENIC SHOCK; CONFIDENCE INTERVAL; CONSERVATIVE TREATMENT; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; FEMALE; HEART SURGERY; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; HUMAN; HYPOKALEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; INTENSIVE CARE UNIT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATIENT CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; SURGICAL PATIENT; SURVIVOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; ADVERSE EFFECTS; CAUSE OF DEATH; CLINICAL TRIAL; FRANCE; HEALTH CARE QUALITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SHOCK, SURGICAL; STATISTICS AND NUMERICAL DATA;

CARDIAC SURGICAL PROCEDURES; CATECHOLAMINES; CAUSE OF DEATH; FEMALE; FRANCE; HEMOFILTRATION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SHOCK, SURGICAL; STANDARD OF CARE;

EID: 84948986925     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201503-0516OC     Document Type: Article

References (51)

1. Algarni KD, Maganti M, Yau TM. Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: trends over 20 years. Ann Thorac Surg 2011;92: 1678-1684.
2. Carrel T, Englberger L, Mohacsi P, Neidhart P, Schmidli J. Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance. J Card Surg 2000;15: 347-353.
3. Levin MA, Lin HM, Castillo JG, Adams DH, Reich DL, Fischer GW. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation 2009;120: 1664-1671.
4. Maganti M, Badiwala M, Sheikh A, Scully H, Feindel C, David TE, Rao V. Predictors of low cardiac output syndrome after isolated mitral valve surgery. J Thorac Cardiovasc Surg 2010;140: 790-796.
5. Maganti MD, Rao V, Borger MA, Ivanov J, David TE. Predictors of low cardiac output syndrome after isolated aortic valve surgery. Circulation 2005;112(Suppl 9): I448-I452.
6. Rao V, Ivanov J, Weisel RD, Ikonomidis JS, Christakis GT, David TE. Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg 1996;112: 38-51.
7. Chew MS. Does modified ultrafiltration reduce the systemic inflammatory response to cardiac surgery with cardiopulmonary bypass? Perfusion 2004;19: S57-S60.
8. Ahmed I, House CM, Nelson WB. Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB). J Cardiothorac Surg 2009;4: 24.
9. Denault AY, Tardif JC, Mazer CD, Lambert J; BART Investigators. Difficult and complex separation from cardiopulmonary bypass in high-risk cardiac surgical patients: a multicenter study. J Cardiothorac Vasc Anesth 2012;26: 608-616.
10. Dixon B, Santamaria J, Campbell D. Coagulation activation and organ dysfunction following cardiac surgery. Chest 2005;128: 229-236.
11. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 1997;112: 676-692.
12. Seeburger J, Hoffmann J, Wendel HP, Ziemer G, Aebert H. Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating. Circulation 2005;112(Suppl. 9): I224-I228.
13. Verrier ED, Shernan SK, Taylor KM, Van de Werf F, Newman MF, Chen JC, Carrier M, Haverich A, Malloy KJ, Adams PX, et al.; PRIMOCABG Investigators. Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. JAMA 2004;291: 2319-2327.
14. Franke A, Lante W, Fackeldey V, Becker HP, Kurig E, Zöller LG, Weinhold C, Markewitz A. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005;28: 569-575.
15. Duggan E, Caraher E, Gately K, O'Dwyer M, McGovern E, Kelleher D, McManus R, Ryan T. Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery. Crit Care Med 2006;34: 2134-2139.
16. Hayashi Y, Sawa Y, Nishimura M, Fukuyama N, Ichikawa H, Ohtake S, Nakazawa H, Matsuda H. Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response. Eur J Cardiothorac Surg 2004;26: 276-280.
17. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365: 63-78.
18. Neumar RW, Nolan JP, Adrie C, Aibiki M, Berg RA, Böttiger BW, Callaway C, Clark RS, Geocadin RG, Jauch EC, et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation 2008;118: 2452-2483.
19. Schmittinger CA, Torgersen C, Luckner G, Schröder DC, Lorenz I, Dünser MW. Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 2012;38: 950-958.
20. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT; The Multicenter Study of Perioperative Ischemia Research Group. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 1998;128: 194-203.
21. Heering P, Grabensee B, Brause M. Cytokine removal in septic patients with continuous venovenous hemofiltration. Kidney Blood Press Res 2003;26: 128-134.
22. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR. Prospective evaluation of short-term, highvolume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28: 3581-3587.
23. RimmeléT, Kellum JA. High-volume hemofiltration in the intensive care unit: a blood purification therapy. Anesthesiology 2012;116: 1377-1387.
24. Joannes-Boyau O, HonoréPM, Perez P, Bagshaw SM, Grand H, Canivet JL, Dewitte A, Flamens C, Pujol W, Grandoulier AS, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013;39: 1535-1546.
25. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, et al.; VA/ NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359: 7-20.
26. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, et al.; RENAL Replacement Therapy Study Investigators. Intensity of continuous renalreplacement therapy in critically ill patients. N Engl J Med 2009;361: 1627-1638.
27. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008;19: 1233-1238.
28. Boussekey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, Georges H, Leroy O. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008;34: 1646-1653.
29. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. Highvolume haemofiltration in human septic shock. Intensive Care Med 2001;27: 978-986.
30. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, Zamperetti N, Brendolan A, D'Intini V, Tetta C, et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006;32: 80-86.
31. Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, Spaulding C, Carli P, Dhainaut JF, Monchi M. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005;46: 432-437.
32. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270: 2957-2963.
33. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138: 720-723.
34. Weinberg PF, Matthay MA, Webster RO, Roskos KV, Goldstein IM, Murray JF. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis 1984;130: 791-796.
35. McCabe WR, Jackson GG. Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 1962;110: 847-855.
36. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40: 373-383.
37. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16: 9-13.
38. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356: 26-30.
39. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006;70: 1312-1317.
40. Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J. Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant 2012;27: 967-973.
41. Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, Bagshaw SM. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011; 15: R72.
42. Vidal S, RichebéP, Barandon L, Calderon J, Tafer N, Pouquet O, Fournet N, Janvier G. Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery. Eur J Cardiothorac Surg 2009;36: 572-579.
43. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002;30: 2205-2211.
44. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002;30: 100-106.
45. Bellomo R, Lipcsey M, Calzavacca P, Haase M, Haase-Fielitz A, Licari E, Tee A, Cole L, Cass A, Finfer S, et al.; RENAL Study Investigators and ANZICS Clinical Trials Group. Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med 2013;39: 429-436.
46. Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011;26: 3508-3514.
47. Schiffl H, Lang SM. Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury. Int Urol Nephrol 2013;45: 191-197.
48. Yang Y, Zhang P, Cui Y, Lang X, Yuan J, Jiang H, Lei W, Lv R, Zhu Y, Lai E, et al. Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care 2013;17: R205.
49. Demirjian S, Teo BW, Paganini EP. Alkalemia during continuous renal replacement therapy and mortality in critically ill patients. Crit Care Med 2008;36: 1513-1517.
50. Jun M, Bellomo R, Cass A, Gallagher M, Lo S, Lee J; Randomized Evaluation of Normal Versus Augmented Level of Replacement Therapy (RENAL) Study Investigators. Timing of renal replacement therapy and patient outcomes in the randomized evaluation of normal versus augmented level of replacement therapy study. Crit Care Med 2014;42: 1756-1765.
51. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E; Hemofiltration and Sepsis Group of the Collège National de Réanimation et de Médecine d'Urgence des Hôpitaux extra- Universitaires. Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 2009;37: 803-810.